Patents by Inventor Rene Huvar

Rene Huvar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human 5-HT3-C protein
    Patent number: 7109296
    Abstract: DNA encoding human 5-HT3-C has been cloned and characterized. The recombinant protein is capable of forming biologically active human 5-HT3-C protein. The cDNA has been expressed in recombinant host cells that produce active recombinant protein. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the receptor activity, and receptor modulators are identified.
    Type: Grant
    Filed: September 12, 2003
    Date of Patent: September 19, 2006
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Adrienne E. Dubin, Mark G. Erlander, Arne Huvar, Rene Huvar, Lukas K. Buehler
  • DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor
    Publication number: 20050124795
    Abstract: DNA encoding human 5-HT3-C has been cloned and characterized. The recombinant protein is capable of forming biologically active human 5-HT3-C protein. The cDNA has been expressed in recombinant host cells that produce active recombinant protein. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the receptor activity, and receptor modulators are identified.
    Type: Application
    Filed: September 12, 2003
    Publication date: June 9, 2005
    Inventors: Adrienne Dubin, Mark Erlander, Arne Huvar, Rene Huvar, Lukas Buehler
  • DNA encoding human acid-sensing ion channel BNaC4 (ASIC4)
    Patent number: 6548270
    Abstract: DNA encoding human acid sensing ion channel BnaC4 has been cloned and characterized. The recombinant protein is capable of forming biologically active protein. The cDNA's have been expressed in recombinant host cells that produce active recombinant protein. The recombinant protein is also purified from the recombinant host cells. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the receptor activity, and receptor modulators are identified.
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: April 15, 2003
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Adrienne Elizabeth Dubin, Jayashree Pyati, Rene Huvar, Mark G. Erlander
  • DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor
    Publication number: 20020137138
    Abstract: DNA encoding human 5-HT3-C has been cloned and characterized. The recombinant protein is capable of forming biologically active human 5-HT3-C protein. The cDNA has been expressed in recombinant host cells that produce active recombinant protein. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the receptor activity, and receptor modulators are identified.
    Type: Application
    Filed: September 12, 2001
    Publication date: September 26, 2002
    Inventors: Adrienne E. Dubin, Mark G. Erlander, Arne Huvar, Rene Huvar, Lukas K. Buehler
  • DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor
    Patent number: 6365370
    Abstract: DNA encoding human 5-HT3-C has been cloned and characterized. The recombinant protein is capable of forming biologically active human 5-HT3-C protein. The cDNA has been expressed in recombinant host cells that produce active recombinant protein. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the receptor activity, and receptor modulators are identified.
    Type: Grant
    Filed: September 1, 1999
    Date of Patent: April 2, 2002
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Adrienne E. Dubin, Mark G. Erlander, Arne Huvar, Rene Huvar, Lukas K. Buehler